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Lipoid proteinosis (LP) is a rare disorder and it can affect every organ in the body. The clini-
cal manifestations of LP may vary considerably between affected individuals. Short stature is
reported in patients with LP however the underlying etiology is not clear. Short stature may be
due to endocrine dysfunction caused by deposition of hyaline-like material in endocrine glands.
We investigated a 13 year old patient with LP (507 delT mutation) who had severe short stature.
He had hoarseness since the age of one year, followed by characteristic skin lesions for LP and
short stature. There was no pathology with respect to endocrinological investigations in our
patient including growth hormone-IGF axis. Our results show that short stature in LP can not be
explained by endocrinological abnormalities. Short stature may be  an intrinsic component of the
syndrome.
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INTRODUCTION
Lipoid proteinosis (LP) is a condition
characterized by the deposition of periodic
acid Schiff-positive hyaline-like material in
various tissues including skin, mucous
membranes and internal organs.(1, 2) The
etiology of LP is currently unknown. It has
been shown that LP results from mutations
in extracellular matrix protein 1 (ECM1)
genes on chromosome 1q21. Although
classical features include laryngeal infiltra-
tion leading to hoarseness, scarring and in-
filtrations of the skin, LP can affect every
organ in the body.(1, 2) Recurrent episo-
des of inflamed parotid and submandibu-
lar glands may occur. A shortened tongue
with a thickened frenulum may also be se-
en.(3) Other extracutaneous features inclu-
de epilepsy and neuropsychiatric abnor-
malities, sometimes in association with cal-
cifications in the temporal lobes or in the
hippocampus.(4, 5) Deposition of hyaline-
like material in the eye may cause corneal
opacities or secondary glaucoma. Intestinal
bleeding may occur as a result of depositi-
on in the small bowel.(6, 7) Lung and
bronchial involvement has also been re-
ported in patients with LP.(8) Insulin resis-
tance was also detected.(9) Chakrabarti et
al.(10) reported a patient with LP and
dwarfism. The cause of dwarfism could
not be elicited in this patient and it was
postulated that the short stature could ha-
ve been due to defective osteoblasts which
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usedocrinological dysfunction was not evalua-
ted in this patient. Recently, short stature
was reported in two LP patients from two
different families.(11) Considering the possi-
bility that short stature in LP patients may be
due to endocrine dysfunction caused by de-
position of hyaline-like material in endocri-
ne glands, we investigated one of the pati-
ents reported below (Patient 1) for endocri-
nological involvement. 
CASE REPORTS
Patient 1. A 13-year-old boy had been re-
ferred to our clinic with a history of hoarse-
ness since the age of one year, followed by
skin lesions and short stature. He was the offs-
pring of a second degree consanguineous
marriage. His height was 128.2 cm, weight
25.9 kg and body mass index 15.8. Expressed
as standard deviation scores (SDS), these va-
lues were –3.9 SDS, –3.1 SDS and –1.6 SDS
respectively, according to age and sex speci-
fic Turkish standards.(12, 13) Sitting he-
ight/height ratio was normal for age (0.52).
Mother’s height was 168.5 cm (0.9 SD) and
father’s height was 175.1 cm (–0.2 SD). Physi-
cal examination revealed multiple acneiform
scars on the face; beaded papules on the mar-
gins of the eyelids; papulovesicular lesions,
scars and skin hyperkeratosis on the hands,
elbows, knees, axilla and buttocks (Figure 1).
Scarring was reported following trauma or in-
jury. The cutaneous changes were unrelated
to sun exposure. The patient’s tongue was
firm, thick, pale, with yellowish-white papules
on its surface. The mobility of the tongue was
restricted by a thickened frenulum. Dentition
was normal. There were no signs of puberty.
Developmental milestones were normal.
Routine blood chemistry, lipid profile,
complete blood count, urine analysis and
stool examination were all within the normal
ranges. Bone age corresponded to age 10
years, according to the Greulich and Pyle
method.(14) The electroencephalogram was
normal. Further investigations were underta-
ken to detect deposition of hyaline-like ma-
terial at various sites. Fundoscopic and slit
lamp examination of the eyes revealed nor-
mal results. Laryngoscopic examination sho-
wed mucosal thickening in the vocal cords
and subglottic region. Serum levels of vita-
min A, zinc and copper were normal.
Hoarseness and characteristic skin
changes of the patient was pathognomonic
for LP. Histopathological examination of
skin biopsy specimen showed orthokeratot-
ic hyperkeratosis and acanthosis of epider-
mis, hyperkeratosis, acanthosis and evident
bunch of collagen arranged in parallel to
surface, and tight and fibrotic appearance of
dermis and ectasia of some small blood ves-
sels, some hyaline material deposition and
hyaline appearance of basal lamina and
fibrosis of papillary dermis. 
The results of endocrinological investiga-
tions are shown in Table 1. Serum levels of
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Figure 1: Multiple acneiform scars on face and beaded papules on the margins of eyelids (a), papulovesicular
lesions, scars and hyperkeratosis on hands (b), elbows and buttocks (c) of lipoid proteinosis patient with
short stature.
(c) (b) (a)thyroid hormone, insulin like growth factor-
I (IGF-I) and IGF-binding protein-3 (IGFBP-
3) were normal. Growth hormone (GH) sec-
retion investigated by GH tests and sensiti-
vity investigated by IGF-1 response to GH
injection did not reveal GH deficiency or GH
insensitivity. Adrenal cortex function was
also normal at insulin tolerance test. Gona-
dotropin-releasing hormone test and testos-
terone response to human chorionic
gonadotropin (HCG) stimulation were wit-
hin normal ranges for age and pubertal sta-
tus, indicative of a normally functioning
hypothalamo-pituitary-gonadal axis.
Oral glucose tolerance test, performed
for evaluation of insulin resistance, revealed
normal results. Magnetic scanning showed
calcification in both amygdals. Pituitary
gland imaging results were unremarkable.
For investigation of osteoblastic activity
and bone turnover, bone mineral density of
the lumbar L1-L4 vertebrae, serum levels of
calcium, phosphorus and bone turnover
markers were evaluated. The results were
normal (Table 2). Endoscopic examination
of the upper gastrointestinal tract and small
bowel biopsy also gave normal results 
Patient 2. The family history of Patient 1
revealed that one of his younger cousins (a
6 years old male) also had a hoarse voice
and very mild cutaneous findings. On exa-
mination, this patient’s height and weight
were at the 10th percentile for age. His men-
tal development was normal. His parents
were also first cousins. 
Informed consent for genetic analysis
was obtained from the families of both pati-
ents. The genetic analyses were performed
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Table 1: Results of endocrinological investigations in Patient 1.
Thyroid hormone
• Free thyroxine 19.8 pmol/L (N:12-24) 
• Thyroid stimulating hormone 2.2 mIU/L (N:0.4-5.5)
Insulin like growth factor-I (IGF-I) 96.1 ng/mL (N:76-278)
IGF binding protein-3 (IGFBP-3) 2328.9 ng/mL (N:2200-5900)
Screening tests for growth hormone Peak growth hormone response
deficiency (with sex steroid) 
• Clonidine stimulation test 19.4 ng/mL
• Insulin stimulation test (ITT) 7.3 ng/mL      
IGF-I  generation test Delta IGF-I:  200 ng/mL
Delta IGFBP-3: 1220 ng/mL
Cortisol
• Basal 6.9 µgl/dL (N:5-15)
• at 60. minute of ITT 21.4 µgl/dL (N>18)
Prolactin 13.7 ng/mL (N:3-18)
Oral glucose tolerance test 0´ 30´ 60´ 90´ 120´
• Glucose (mg/dL) 66 126 101 85 82
• Insulin (mU/L) 3.8 80 46 30.6 16.9
Gonadotropin-releasing hormone test 0´ 30´ 60´ 90´
• Follicle-stimulating hormone (IU/L) 0.1 1.8 2.8 2.4
• Luteinising hormone (IU/L) 0.8 2.8 5.3 6.2
Testosterone 0.08 ng/mL
Short human chorionic gonadotropin test
(1500 IU/m2 per day - 3 days) 
• Testosterone Basal After 3 days 
0.11 ng/mL 1.34 ng/mLin St John’s Institute of Dermatology, Lon-
don, UK. Both patients were homozygous
for mutation 507delT in exon 6 of ECM1. Ge-
netic analysis of the parents yielded a hete-
rogeneous mutation 507delT in both parents
of patient 1 and in the father of patient 2. 
DISCUSSION
LP results from mutations in ECM1, a
glycoprotein expressed in several tissues
including the skin. This glycoprotein is com-
posed of two alternatively spliced isoforms,
ECM1a and ECM1b, the latter lacking exon 7
of this 10-exon gene. The mutations map
onto chromosome 1q21. To date, mutations
that either affect ECM1a alone or that disturb
both ECM1 transcripts have been demonstra-
ted in several cases. Over 20 different muta-
tions have been detected throughout the
world.(1, 2) Exons 6 and 7 are the most
common sites for ECM1 mutations in LP. Cli-
nically, it appears that mutations outside
exon 7 are usually associated with a slightly
more severe mucocutaneous LP phenotype.
Neurological features do not show any spe-
cific genotype-phenotype correlation.(1, 2)
The clinical manifestations of LP may
vary considerably between affected individu-
als. Individuals with the same genetic back-
ground and the identical mutation were
shown to have a vastly different phenoty-
pe.(1, 2) Homozygous 507delT mutation was
detected in our patients. Although both of
our patients have the same mutation, the se-
verity of disease was very different in the two
patients. This particular mutation has been
documented previously. Two Thai brothers
with temporal lobe epilepsy and a 3-year-old
Iranian male only with skin lesions and ho-
arseness were reported.(2) Uchida et al.(15)
detected the same mutation in a patient with
mucocutaneous lymphangiogenesis.
Chakrabarti et al.(10) reported a patient
with LP and dwarfism. The cause of dwarfism
could not be elicited in this patient and it was
postulated that the short stature may have be-
en be due to defective osteoblasts which are
biologically similar to fibroblasts. Our patient
also has short stature. However, his osteob-
lastic activity markers, bone turnover markers
and bone mineral density were all normal.
Endocrinological investigations based on
the possibility that short stature in LP patients
may be due to endocrine dysfunction caused
by deposition of hyaline-like material in the
endocrine glands also failed to detect any en-
docrinological organ involvement. 
Our results show that short stature in LP
cannot be explained by endocrinological ab-
normalities. We postulate that short stature
in LP patients probably constitutes one of
the components of this rare syndrome with
a hitherto unknown etiology. Further cases
with short stature, if any, will enlighten this
association. 
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